MedTrace Logo

Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent Symptoms

NCT01880619 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2015-11-25

No results posted yet for this study

Summary

This study will be conducted to compare the effectiveness of alpha blocker (Tamsulosin) and Anticholinergic (Solifenacin) in relieving lower urinary tract symptoms caused DJ ureteral stents.

Conditions

  • Relieve of Ureteral Stent Symptoms

Interventions

DRUG

Tamsulosin

Patients in this arm will receive Tamsulosin 0.4 mg daily

DRUG

Solifenacin

Patients in the arm will receive Solifenacin

DRUG

Control

Patients in this are will receive placebo

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Ahmed R EL-Nahas, A. Professor · Urology and Nephrology Center, Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-05-31
Completion
2014-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01880619 on ClinicalTrials.gov